• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Vertex Pharma Tops Quarterly Views On Strong Cystic Fibrosis Drug Sales

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 26, 2018 at 07:42: PM
via Vertex Pharmaceuticals (VRTX) smashed first-quarter expectations late Thursday, reiterated its 2018 guidance and announced that another triple-pill regimen for cystic fibrosis will head into Phase 3 studies.

article source
 




Top Bottom
Back
Quote